Navigation Links
Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China
Date:7/31/2014

HARBIN, China, July 31, 2014 /PRNewswire/ -- Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), health beverages and organic and specialty foods, today announced the signing of its first distributor for its new Cordyceps powder solution product and its expansion to Hubei Province located in the eastern part of Central China.

The contract with the new distributor, Hubei Quandu Aiwan Health Industry Co., Ltd. ("Aiwan") was signed on July 16, 2014 and is for an initial period of one year (subject to additional extension or renewal thereafter) with a commitment of up to RMB 20 million per year (US $3.2 million) for the Cordyceps' powder solution product only. Introduced by Beijing MLTH Fortune Investment Management Co., Ltd. (MLTH), the strategic investor that participated in the Company's June 2014 private transaction, Aiwan distributes healthcare related products throughout the region.

Through the new distributor, Nutrastar's premium Cordyceps powder solution product will be distributed to targeted specialty nutraceuticals stores and supermarkets. The soluble Cordyceps product will come in a 140g per box size and will be used as a nutritional supplement for health-conscious consumers "on-the-go".

Hubei, a province with a 2010 population of approximately 57 million, is known to support industries that include automobiles, machinery, power generation, and high-tech commodities. Wuhan, the provincial capital and largest city with a 2010 population of approximately 9.8 million, is a major transportation thoroughfare and the political, cultural, and economic hub of Central China.

Ms. '/>"/>

SOURCE Nutrastar International Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nutrastar International Inc. Announces That Acclaimed Value Investor, Accretive Capital Partners, Significantly Increased Its Ownership of the Company through Private Transactions
2. Nutrastar Releases Record Third Quarter 2013 Results
3. Nutrastar Releases Second Quarter 2013 Results
4. Nutrastar Announces First Quarter 2013 Results, Maintains Full Year Revenue Guidance Range of $44 million to $46 Million
5. Nutrastar Announces Full Year 2012 Results, Issues 2013 Revenue Guidance
6. Nutrastar International Completes Multi-Year Production Expansion Project Bringing Cordyceps Capacity to 100 Tons
7. The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF)
8. Creekridge Capital Signs Several New Vendor Partners
9. The Medicines Patent Pool Signs a Record Seven New Sub-Licences to Speed the Availability of Generic HIV Medicines to Developing Countries
10. Vasomedical Signs Agreement with GE Healthcare IT to Become National Value Added Reseller for Radiology PACS Software Solutions
11. Z-Medica Signs HealthTrust Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014 Research and ... addition of the "Global Gynecological Devices ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... into wide categories based on their operations. ... of different gynecological conditions that affect the ...
(Date:9/19/2014)... , Sept. 19, 2014  The board of ... declared a quarterly cash dividend of $0.42 per share.  ... 17, 2014 to stockholders of record at the close ... AbbVie AbbVie is a global, research-based biopharmaceutical company formed ... is to use its expertise, dedicated people and unique ...
(Date:9/19/2014)... , Sept. 19, 2014  For Cloud Pharmaceuticals, ... design and development, partnering is an integral part ... to design new drugs and identify early stage, ... to further their development. The company also partners ... support this business model, Cloud Pharmaceuticals will be ...
Breaking Medicine Technology:Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 3Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2
... Mass. and SYDNEY, Dec. 2, 2010 HeartWare International, ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that CEO Doug Godshall is scheduled to ... & Obesity Conference on Tuesday, December 7, 2010 at ...
... Dec. 2, 2010 Sagent Pharmaceuticals, Inc., a ... approval and launch of its topotecan hydrochloride for ... innovator,s patent expiry.  Sagent,s topotecan is available in ... latest product to feature Sagent,s proprietary PreventIV Measures™ ...
Cached Medicine Technology:HeartWare to Present at the Canaccord Genuity Cardio/Diabetes & Obesity Conference 2Sagent Pharmaceuticals Adds to Its Oncology Portfolio With Launch of Topotecan Hydrochloride for Injection 2
(Date:9/20/2014)... Weight Destroyer , a weight ... Michael Wren that has already helped tens of thousands ... conditions like high blood pressure, high cholesterol, and accelerated ... an investigative review. , “Weight Destroyer is totally ... by showing people what is truly effective when it ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 Villa del ... resort did not experience any damage in relation to ... and activities available. , Hurricane Odile struck Cabo San ... wind, rain and powerful surf conditions. Located on the ... Islands of Loreto experienced some heavy rain, but no ...
(Date:9/20/2014)... On Monday, September 22, Loma Linda ... research grant from Hyundai Hope on Wheels at a ... located on 11234 Anderson St., in Loma Linda. The ... Associate Professor at Loma Linda University and Director of ... children. , Loma Linda University Medical Center ...
(Date:9/20/2014)... The avian flu that killed 160 harbor seals in ... drops and therefore poses a potential threat to humans, ... illnesses have been linked to the harbor seal virus, ... natural mutations to the avian H3N8 seal virus that ... droplets. Current seasonal flu vaccines wouldn,t help in ...
(Date:9/20/2014)... September 20, 2014 New PharmaPoint ... Market Analysis to 2023?. The asthma market saw ... it has become saturated with relatively efficacious standard ... (ICSs), inhaled corticosteroids and long-acting beta-agonists (ICS/LABAs), and ... generic competition. However, the launch of seven novel ...
Breaking Medicine News(10 mins):Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 3Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 3Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 2Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 3Health News:Avian Flu In Harbor Seals Could Infect People 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 3Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 4
... French . Montreal, July 14, 2010 ... to a new study from the University of Montreal (Canada) ... Molecular Nutrition & Food Research , the investigation analyzed ... notably whether cashew extracts could improve the body,s response to ...
... psychologist at the University of Georgia shows that behavioral economic ... alcohol and other drugs. This method of studying how ... fairly new, but according to the study, it may well ... effective ways to defeat addictions. The research was published ...
... INDIANAPOLIS Pain and depression associated with cancer ... be significantly reduced through centralized telephone-based care management ... from the Regenstrief Institute and Indiana University School ... Depression (INCPAD) study combined automated calls with follow-up ...
... Doheny HealthDay Reporter , TUESDAY, July 13 (HealthDay ... last ",til death do you part" -- or if you ... game may reveal the hidden truth about your union, a ... flawed because it relies on asking the people involved how ...
... protein already used to treat diseases like multiple sclerosis, hepatitis ... patients, UT Southwestern Medical Center researchers have found. ... of a population of immune cells known to cause asthma. ... called T helper 2 cells, or Th2 cells. Under normal ...
... Gardner HealthDay Reporter , TUESDAY, July 13 (HealthDay ... than a decade ago that the blockbuster diabetes drug caused ... information, according to a report published Tuesday in The ... Avandia against its competitor, Actos, the drug company, then known ...
Cached Medicine News:Health News:New analysis may help clarify the role of craving in addiction 2Health News:New analysis may help clarify the role of craving in addiction 3Health News:Help is on the phone: Reducing pain and depression of cancer 2Health News:Word Games May Predict Life of Relationship 2Health News:Word Games May Predict Life of Relationship 3Health News:Interferon might help asthma patients breathe easier, UT Southwestern study suggests 2Health News:Avandia Heart Risks Buried by Drug Company: Report 2Health News:Avandia Heart Risks Buried by Drug Company: Report 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: